Pathogenicity and virulence of Mycobacterium tuberculosis

KC Rahlwes, BRS Dias, PC Campos… - Virulence, 2023 - Taylor & Francis
Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis, an infectious
disease with one of the highest morbidity and mortality rates worldwide. Leveraging its …

Nanocarriers for the delivery of antibiotics into cells against intracellular bacterial infection

C Wang, Y Yang, Y Cao, K Liu, H Shi, X Guo… - Biomaterials …, 2023 - pubs.rsc.org
The barrier function of host cells enables intracellular bacteria to evade the lethality of the
host immune system and antibiotics, thereby causing chronic and recurrent infections that …

Virion glycosylation influences mycobacteriophage immune recognition

KG Freeman, AC Robotham, OB Parks, L Abad… - Cell Host & Microbe, 2023 - cell.com
Glycosylation of eukaryotic virus particles is common and influences their uptake, trafficking,
and immune recognition. In contrast, glycosylation of bacteriophage particles has not been …

[HTML][HTML] The antimicrobial activity of innate host-directed therapies–a systematic review

T Shapira, M Christofferson, Y Av-Gay - International Journal of …, 2024 - Elsevier
Intracellular human pathogens are the deadliest infectious diseases and pose great difficulty
to effectively treat due to their protection inside the host cell and the development of …

Spermine enhances the activity of anti-tuberculosis drugs

C Sao Emani, N Reiling - Microbiology Spectrum, 2024 - Am Soc Microbiol
The discovery of molecules that could shorten the treatment period of tuberculosis (TB)
holds the promise of improving the current regimen. Polyamines are organic polycationic …

Lipid-based nanomedicines for the treatment of bacterial respiratory infections: Current state and new perspectives

EM Arroyo-Urea, M Lázaro-Díez, J Garmendia… - …, 2024 - Taylor & Francis
The global threat posed by antimicrobial resistance demands urgent action and the
development of effective drugs. Lower respiratory tract infections remain the deadliest …

Human Kinase IGF1R/IR Inhibitor Linsitinib Controls the In Vitro and Intracellular Growth of Mycobacterium tuberculosis

H Wang, J Bi, Y Zhang, M Pan, Q Guo… - ACS Infectious …, 2022 - ACS Publications
ATP provides energy in the biosynthesis of cellular metabolites as well as regulates protein
functions through phosphorylation. Many ATP-dependent enzymes are antibacterial and …

The efflux pumps Rv1877 and Rv0191 play differential roles in the protection of Mycobacterium tuberculosis against chemical stress

C Sao Emani, N Reiling - Frontiers in Microbiology, 2024 - frontiersin.org
Background It was previously shown that GlnA3sc enabled Streptomyces coelicolor to
survive in excess polyamines. However, subsequent studies revealed that Rv1878, the …

Glycogen synthase kinase 3 inhibition controls Mycobacterium tuberculosis infection

S Peña-Díaz, JD Chao, C Rens, H Haghdadi, X Zheng… - Iscience, 2024 - cell.com
Compounds targeting host control of infectious diseases provide an attractive alternative to
antimicrobials. A phenotypic screen of a kinase library identified compounds targeting …

Synthesis, structures, reactivity and medicinal chemistry of antitubercular benzothiazinones

RW Seidel, A Richter, R Goddard… - Chemical …, 2023 - pubs.rsc.org
Tuberculosis is the leading bacterial killer worldwide. 8-Nitro-4H-benzo [e][1, 3] thiazin-4-
ones are a potent class of antitubercular agents with a new mechanism of action. BTZ043 …